Corrigendum to

Zan Song; Hao Dong; Kailing Zhang; Bingke Qiao; Leilei Li; Zhicheng Zhang; Zhili Fan; Jing Li; Yu Li; Mengfei Liu; Ying Liu; Xinyu Gu; Tao Zhang

doi:10.1016/j.pscia.2025.100081

Pharmaceutical Science Advances ›› 2025, Vol. 3 ›› Issue (1) : 100081 DOI: 10.1016/j.pscia.2025.100081

Perspective

research-article

Corrigendum to "GLDC interacts with VPS34 to inhibit tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma" [Adv. Pharmaceut. Sci. (3), (2025), 100072]

Author information +

History +

PDF (373KB)

Cite this article

Download citation ▾

Zan Song, Hao Dong, Kailing Zhang, Bingke Qiao, Leilei Li, Zhicheng Zhang, Zhili Fan, Jing Li, Yu Li, Mengfei Liu, Ying Liu, Xinyu Gu, Tao Zhang. Corrigendum to "GLDC interacts with VPS34 to inhibit tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma" [Adv. Pharmaceut. Sci. (3), (2025), 100072]. Pharmaceutical Science Advances, 2025, 3(1): 100081 DOI:10.1016/j.pscia.2025.100081